Zobrazeno 1 - 10
of 10 834
pro vyhledávání: '"Phase I as Topic"'
Autor:
Chen X; Department of Biostatistics, China Pharmaceutical University, Nanjing, China., Zhang J; Department of Biostatistics, China Pharmaceutical University, Nanjing, China., Li B; Department of Biostatistics, China Pharmaceutical University, Nanjing, China., Yan F; Department of Biostatistics, China Pharmaceutical University, Nanjing, China. f.r.yan@163.com.
Publikováno v:
BMC medical research methodology [BMC Med Res Methodol] 2024 Nov 08; Vol. 24 (1), pp. 270. Date of Electronic Publication: 2024 Nov 08.
Autor:
Jaki T; Faculty for Informatics and Data Science, University Regensburg, Germany.; MRC Biostatistics Unit, University of Cambridge, UK., Barnett H; School of Mathematical Sciences, Lancaster University, UK., Titman A; School of Mathematical Sciences, Lancaster University, UK., Mozgunov P; MRC Biostatistics Unit, University of Cambridge, UK.
Publikováno v:
Statistical methods in medical research [Stat Methods Med Res] 2024 Nov; Vol. 33 (11-12), pp. 2115-2130. Date of Electronic Publication: 2024 Oct 14.
Autor:
Kawabe Y; Research Division, Chugai Pharmaceutical Co., Ltd, 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa 2449602, Japan. Electronic address: kawabeysk@chugai-pharm.co.jp., Himori M; Research Division, Chugai Pharmaceutical Co., Ltd, 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa 2449602, Japan., Watanabe Y; Research Division, Chugai Pharmaceutical Co., Ltd, 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa 2449602, Japan., Davis J; Research Division, Chugai Pharmaceutical Co., Ltd, 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa 2449602, Japan., Hamada H; Research Division, Chugai Pharmaceutical Co., Ltd, 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa 2449602, Japan.
Publikováno v:
Drug discovery today [Drug Discov Today] 2024 Nov; Vol. 29 (11), pp. 104200. Date of Electronic Publication: 2024 Oct 09.
Autor:
Caquelin L; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Badra P; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France.; ReCAP/F-CRIN, INSERM, Paris, France., Poulain L; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Laviolle B; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Ursino M; ReCAP/F-CRIN, INSERM, Paris, France.; Unit of Clinical Epidemiology, Assistance Publique-Hôpitaux de Paris, CHU Robert Debré, Inserm CIC-EC 1426, Paris, France.; Inserm, Centre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université, Paris, France.; Inria Paris, Paris, France., Locher C; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France.; ReCAP/F-CRIN, INSERM, Paris, France.
Publikováno v:
Research synthesis methods [Res Synth Methods] 2024 Nov; Vol. 15 (6), pp. 964-977. Date of Electronic Publication: 2024 Aug 05.
Autor:
Ghosh S; Department of Computer Science, University of New Hampshire, Durham, New Hampshire, United States of America., Abushukair HM; Jordan University of Science and Technology, Irbid, Jordan., Ganesan A; School of Computer Science, University of Oklahoma Norman Campus, Norman, Oklahoma, United States of America., Pan C; School of Computer Science, University of Oklahoma Norman Campus, Norman, Oklahoma, United States of America., Naqash AR; Medical Oncology/ TSET Phase 1 Program, Stephenson Cancer Center, The University of Oklahoma Health Science Campus, Oklahoma City, Oklahoma, United States of America., Lu K; School of Library and Information Studies, University of Oklahoma Norman Campus, Norman, Oklahoma, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Oct 24; Vol. 19 (10), pp. e0311510. Date of Electronic Publication: 2024 Oct 24 (Print Publication: 2024).
Autor:
Russo M; Department of Statistics, The Ohio State University, Columbus, OH., Mariani F; Dipartimento di Scienze Statistiche, Sapienza University of Rome, Rome, Italy., Cleary JM; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Shapiro GI; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Coté GM; Harvard Medical School, Boston, MA.; Mass General Cancer Center, Boston, MA., Trippa L; Dana-Farber Cancer Institute, Boston, MA.; T.H. Chan School of Public Health, Harvard University, Cambridge, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Oct; Vol. 8, pp. e2400275. Date of Electronic Publication: 2024 Oct 21.
Autor:
Walker LE; Centre for Experimental Therapeutics, University of Liverpool, Liverpool, UK.; NIHR Liverpool Clinical Research Facility, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Stackpoole M; NIHR Liverpool Clinical Research Facility, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Hodge D; Centre for Experimental Therapeutics, University of Liverpool, Liverpool, UK., FitzGerald R; Centre for Experimental Therapeutics, University of Liverpool, Liverpool, UK.; NIHR Liverpool Clinical Research Facility, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Oct; Vol. 90 (10), pp. 2343-2348. Date of Electronic Publication: 2024 May 09.
Autor:
Wang Y; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Publikováno v:
Statistics in medicine [Stat Med] 2024 Sep 30; Vol. 43 (22), pp. 4361-4371. Date of Electronic Publication: 2024 Jul 29.
Autor:
Vallejo S; Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA., Mahalingam D; Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA; Feinberg School of Medicine at Northwestern University, Chicago, IL, USA., Court C; Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA., Ketchum N; Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA., Gelfond J; Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA., Michalek J; Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA., Arora SP; Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA. Electronic address: aroras@uthscsca.edu.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2024 Sep; Vol. 15 (7), pp. 101816. Date of Electronic Publication: 2024 Jun 20.
Autor:
Hitchen N; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia., Shahnam A; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia., Manoharan S; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia., Topp M; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia., Mileshkin L; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Lim AM; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Whittle JR; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Personalised Oncology Division, Walter and Eliza Hall Institute, Parkville, Australia., Luen SJ; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Solomon B; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Lackovic K; Cancer Trials Australia, Melbourne, Australia., Desai J; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Cancer Trials Australia, Melbourne, Australia., Tran B; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Personalised Oncology Division, Walter and Eliza Hall Institute, Parkville, Australia.; Cancer Trials Australia, Melbourne, Australia.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Dec; Vol. 20 (6), pp. 731-737. Date of Electronic Publication: 2024 Jun 24.